Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

PURPOSE/BACKGROUND: This post hoc analysis examined the time point at which clinically significant improvement in major depressive disorder (MDD) symptoms occurs with desvenlafaxine versus placebo. METHODS: Data were pooled from 9 short-term, double-blind, placebo-controlled studies in adults with M...

Descripción completa

Detalles Bibliográficos
Autores principales: Katzman, Martin A., Nierenberg, Andrew A., Wajsbrot, Dalia B., Meier, Ellen, Prieto, Rita, Pappadopulos, Elizabeth, Mackell, Joan, Boucher, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596832/
https://www.ncbi.nlm.nih.gov/pubmed/28817491
http://dx.doi.org/10.1097/JCP.0000000000000775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596832/
https://www.ncbi.nlm.nih.gov/pubmed/28817491
http://dx.doi.org/10.1097/JCP.0000000000000775

Ejemplares similares